LF

본문 바로가기

Investor Relations

We are committed to increasing shareholder value through strengthening of corporate values and proactively promoting IR activities.

Income Statement

Balance Sheet
ITEM	19th 1Q	18th	17th	16th	15th
Noncurrent assets	15,620	15,062	12,383	11,968	11,543
Current assets	12,385	12,494	13,458	13,443	13,251
Total Assets	28,005	27,556	25,840	25,411	24,794
Controlling interest	15,386	15,281	14,689	13,349	12,335
Issued capital	1,462	1,462	1,462	1,462	1,462
Consolidated capital surplus	2,136	2,136	2,137	2,131	2,131
Consolidated capital adjustment	(263)	(186)	(186)	(160)	(110)
Consolidated retained earnings	12,050	11,886	11,294	9,948	8,893
Consolidated accumulated other comprehensive income	1	(16)	(19)	(32)	(41)
Non-controlling interest	1,906	1,855	1,880	1,635	1,809
Total stockholders’ equity	17,292	17,136	16,568	14,984	14,144
Noncurrent liabilities	4,387	2,258	1,844	4,296	3,442
Current liabilities	6,325	8,162	7,428	6,132	7,208
Total liabilities	10,713	10,421	9,272	10,428	10,650
Total stockholders’ equity and liabilities	28,005	27,556	25,840	25,411	24,794

Income Statement
ITEM	19th 1Q	18th 1Q	18th	17th	16th	15th
Revenue	9,158	9,155	19,007	19,685	17,931	16,105
Costs of goods sold	(3,973)	(3,886)	8,063	(7,982)	(6,950)	(7,133)
Gross profit	5,185	5,269	10,944	11,704	10,981	8,971
Selling and administrative expenses	(4,722)	(5,294)	(10,370)	9,852	9,392	(8,201)
Operating profit	463	(25)	574	1,852	1,589	771
Finance income	75	76	130	109	63	62
Finance costs	(160)	(54)	(225)	(104)	(127)	(107)
Other non-operating income and expense	100	128	243	574	736	151
Other non-operating expenses	(49)	(91)	(159)	(234)	(310)	(369)
Investment Income Using the Equity Method	31	10	29	41	42	38
Income before income tax expense	459	44	628	2,238	1,994	545
Income tax expense	(59)	(169)	172	(465)	(632)	(259)
Consolidated net income	400	211	801	1,773	1,362	286

Summary of Financial Statement

Balance Sheet
ITEM	19th 1Q	18th	17th	16th	15th
Noncurrent assets	13,147	12,453	12,237	10,847	9,791
Current assets	6,726	7,095	7,500	7,537	7,305
Total Assets	19,873	19,548	19,737	18,384	17,097
Issued capital	1,462	1,462	1,462	1,462	1,462
Capital surplus	2,132	2,132	2,132	2,132	2,132
Elements of other stockholder's equity	(197)	(141)	(139)	(134)	(94)
retained earnings	12,479	12,332	11,763	10,452	9,155
Other Comprehensive income/loss	(21)	(39)	(40)	(61)	(69)
accumulated amount	15,854	15,746	15,178	13,851	12,585
Noncurrent liabilities	896	1,244	1,268	2,428	2,202
Current liabilities	3,122	2,558	3,292	2,106	2,310
Total liabilities	4,018	3,802	4,559	4,534	4,512
Total stockholders’ equity and liabilities	19,873	19,548	19,737	18,384	17,097

Income Statement
ITEM	19th 1Q	18th 1Q	18th	17th	16th	15th
Revenue	6,147	6,380	12,726	12,719	11,455	11,159
Costs of goods sold	(2,444)	(2,449)	(4,908)	(4,921)	(4,440)	(4,665)
Gross profit	3,703	3,931	7,818	7,798	7,015	6,494
Selling and administrative expenses	(3,386)	(3,671)	(7,266)	(7,040)	(6,234)	(6,016)
Operating profit	317	261	552	758	780	477
Finance income	60	67	129	107	69	64
Finance costs	(71)	(32)	(136)	(63)	(71)	(71)
Other non-operating income and expense	73	87	169	499	709	428
Other non-operating expenses	(34)	(59)	(90)	(185)	(83)	(189)
Using the Equity Method	61	(87)	65	595	388	(168)
Income before income tax expense	407	237	689	1,709	1,792	541
Income tax expense	(60)	(97)	134	(151)	(363)	(144)
Consolidated net income	347	334	823	1,558	1,430	397